Epigenetic histone H3 lysine 9 methylation in metabolic memory and inflammatory phenotype of vascular smooth muscle cells in diabetes

Proceedings of the National Academy of Sciences of the United States of America

Volumn 105, Issue 26, 2008, Pages 9047-9052

  Villeneuve, Louisa M ^a   Reddy, Marpadga A ^a   Lanting, Linda L ^a   Wang, Mei ^a   Meng, Li ^a   Natarajan, Rama ^a  

^a CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

Author keywords

Chromatin; Diabetic inflammation; H3K9me3; Suv39h1

Indexed keywords

GLUCOSE; HISTONE H3; LYSINE; SHORT HAIRPIN RNA; HETEROCHROMATIN SPECIFIC NONHISTONE CHROMOSOMAL PROTEIN HP 1; HETEROCHROMATIN-SPECIFIC NONHISTONE CHROMOSOMAL PROTEIN HP-1; HISTONE; METHYLTRANSFERASE; NONHISTONE PROTEIN; REPRESSOR PROTEIN; SUV39H1 PROTEIN, HUMAN; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATHEROGENESIS; BRAIN DYSFUNCTION; CELL CULTURE; CELL PROTECTION; CHROMATIN; CONTROLLED STUDY; DIABETIC PATIENT; EPIGENETICS; GENE EXPRESSION; GENE OVEREXPRESSION; GENE SILENCING; IMMUNOBLOTTING; IN VITRO STUDY; INFLAMMATION; METHYLATION; MOUSE; MOUSE STRAIN; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROMOTER REGION; SMOOTH MUSCLE FIBER; ANIMAL; DIABETES MELLITUS; DRUG EFFECT; GENETIC EPIGENESIS; GENETICS; HUMAN; IMMUNOLOGICAL MEMORY; IMMUNOLOGY; METABOLISM; PATHOLOGY; PROTEIN BINDING; VASCULAR SMOOTH MUSCLE;

MUS;

ANIMALS; CHROMOSOMAL PROTEINS, NON-HISTONE; DIABETES MELLITUS; EPIGENESIS, GENETIC; GLUCOSE; HISTONES; HUMANS; IMMUNOLOGIC MEMORY; INFLAMMATION; LYSINE; METHYLATION; METHYLTRANSFERASES; MICE; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; PHENOTYPE; PROMOTER REGIONS (GENETICS); PROTEIN BINDING; REPRESSOR PROTEINS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 48249127225     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.0803623105     Document Type: Article

References (30)

1. Nathan DM, et al. (2005) Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Study Research Group. Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. N Engl J Med 353:2643-2653.
2. Ihnat MA, Thorpe JE, Ceriello A (2007) Hypothesis: The "metabolic memory", the new challenge of diabetes. Diabetic Med 24:582-586.
3. Jenuwein T, Allis CD (2001) Translating the histone code. Science 293:1074-1079.
4. Martin C, Zhang Y (2005) The diverse functions of histone lysine methylation. Nature 6:838-849.
5. Peters AH, et al. (2003) Partitioning and plasticity of repressive histone methylation states in mammalian chromatin. Mol Cell 12:1577-1589.
6. Shilatifard A (2006) Chromatin modifications by methylation and ubiquitination: Implications in the regulation of gene expression. Annu Rev Biochem 75:243-69.
7. Lachner M, Jenuwein T (2002) The many faces of histone lysine methylation. Curr Opin Cell Biol 14:286-98.
8. Saccani S, Natoli G (2002) Dynamic changes in histone H3 Lys 9 methylation occurring at tightly regulated inducible inflammatory genes. Genes Dev 16:2219-2224.
9. Foster SL, Hargreaves DC, Medzhitov R (2007) Gene-specific control of inflammation by TLR-induced chromatin modifications. Nature 447:972-980.
10. Gazzar ME, Yoza BK, Hu TY, Cousart SL, McCall CE (2007) Epigenetic silencing of TNFα during endotoxin tolerance. J Biol Chem 282:26857-26864.
11. Shi Y, Whetstine JR (2007) Dynamic regulation of histone lysine methylation by demethylases. Mol Cell 25:1-14.
12. Libby P, Plutzky J (2002) Diabetic macrovascular disease. The glucose paradox? Circulation 106:2760-2763.
13. Glass CK, Witztum JL (2001) Atherosclerosis. The road ahead. Cell 104:503-516.
14. Devaraj S, et al. (2006) Increased monocytic activity and biomarkers of inflammation in patients with type 1 diabetes. Diabetes 55:774-779.
15. Dandona P, Aljada A, Bandyopadhyay A (2005) Inflammation: The link between insulin resistance, obesity and diabetes. Trends Immunol 25:4-7.
16. Wautier MP, Boulanger E, Guillausseau PJ, Massin P, Wautier JL (2004) AGEs, macrophage colony stimulating factor and vascular adhesion molecule blood levels are increased in patients with diabetic microangiopathy. Thromb Haemost 91:879-885.
17. Lee GH, et al. (1996) Abnormal splicing of the leptin receptor in diabetic mice. Nature 379:632-635.
18. Li S-L, et al. (2006) Enhanced pro-atherogenic responses in macrophages and vascular smooth muscle cells derived from diabetic db/db mice. Diabetes 55:2611-2619.
19. Reddy MA, et al. (2006) Key role of Src kinase in S100b-induced activation of the receptor for advanced glycation end products in vascular smooth muscle cells. J Biol Chem 281:13685-13693.
20. Yerneni KK, Bai W, Khan BV, Medford RM, Natarajan R (1999) Hyperglycemia-induced activation of nuclear transcription factor κB in vascular smooth muscle cells. Diabetes 48:855-864.
21. Bierhaus A, et al. (2001) Diabetes-associated sustained activation of the transcription factor, nuclear factor-κB. Diabetes 50:2792-2808.
22. Zhang CL, McKinsey TA, Olson EN (2002) Association of class II histone deacetylases with heterochromatin protein 1: Potential role for histone methylation in control of muscle differentiation. Mol Cell Biol 22:7302-7312.
23. Mal AK (2006) Histone methyltransferase Suv39h1 represses MyoD-stimulated myogenic differentiation. EMBO J 25:3323-3334.
24. Stewart DM, Li J, Wong J (2005) Relationship between histone H3 lysine 9 methylation, transcription repression and heterochromatin protein 1 recruitment. Mol Cell Biol 25:2525-2538.
25. Czvitkovich S, et al. (2001) Over-expression of the SUV39H1 histone methyltransferase induces altered proliferation and differentiation in transgenic mice. Mech Dev 107:141-153.
26. Brownlee M (2001) Biochemistry and molecular cell biology of diabetic complications. Nature 414:813-820.
27. Pfaffl MW (2001) A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 29:e45.
28. Sahar S, et al. (2007) Cooperation of SRC-1 and p300 with NF-kB and CREB in angiotensin II-induced IL-6 expression in vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 27:1528-1534.
29. Li S-L, et al. (2005) Effects of silencing leukocyte-type 12/15-lipoxygenase using short interfering RNAs. J Lipid Res 46:220-229.
30. Ait-Si-Ali S, et al. (2004) A Suv39h-dependent mechanism for silencing S-phase genes in differentiation but not in cycling cells. EMBO J 23:605-615.